Marsh & McLennan Reports Strong Q2 Earnings with 9% Adjusted EPS Growth and $750M Share Buyback
MRSH sits 16% above its 52-week low of $156.6.
Summary
Marsh & McLennan reported robust Q2 2026 financial results, featuring 5% underlying revenue growth, 9% adjusted EPS growth, and $750 million in share repurchases.
Key Events · Earnings and Guidance · MRSH
-
Q2 Revenue Growth
Consolidated revenue increased 6% (5% on an underlying basis) to $7.4 billion for the second quarter of 2026.
-
Adjusted EPS Growth
Adjusted diluted earnings per share (EPS) rose 9% to $2.96 for Q2 2026.
-
Share Repurchases
The company repurchased 4.5 million shares of stock for $750 million in the second quarter of 2026, contributing to a total of $1.5 billion in repurchases through the first half of the year under its existing program.
-
Operating Income Increase
GAAP operating income increased 4% to $1.9 billion, while adjusted operating income rose 5% to $2.2 billion.
Analysis · MRSH · Finance
Marsh & McLennan delivered solid second-quarter results, showing strong underlying revenue growth and a significant increase in adjusted earnings per share. The company also executed a substantial share repurchase program, returning capital to shareholders. These results indicate a strong operational performance following the Greensill litigation charge reported in Q1.
At the time of this filing, MRSH was trading at $182.00 on NYSE in the Finance sector, with a market capitalization of approximately $87.7B. The 52-week trading range was $156.60 to $213.80. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.